Cargando…
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306102/ https://www.ncbi.nlm.nih.gov/pubmed/35869553 http://dx.doi.org/10.1186/s12943-022-01617-6 |
| _version_ | 1784752473637912576 |
|---|---|
| author | Donzelli, Sara Cioce, Mario Sacconi, Andrea Zanconato, Francesca Daralioti, Theodora Goeman, Frauke Orlandi, Giulia Di Martino, Simona Fazio, Vito Michele Alessandrini, Gabriele Telera, Stefano Carosi, Mariantonia Ciliberto, Gennaro Botti, Claudio Strano, Sabrina Piccolo, Stefano Blandino, Giovanni |
| author_facet | Donzelli, Sara Cioce, Mario Sacconi, Andrea Zanconato, Francesca Daralioti, Theodora Goeman, Frauke Orlandi, Giulia Di Martino, Simona Fazio, Vito Michele Alessandrini, Gabriele Telera, Stefano Carosi, Mariantonia Ciliberto, Gennaro Botti, Claudio Strano, Sabrina Piccolo, Stefano Blandino, Giovanni |
| author_sort | Donzelli, Sara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9306102 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93061022022-07-23 A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions Donzelli, Sara Cioce, Mario Sacconi, Andrea Zanconato, Francesca Daralioti, Theodora Goeman, Frauke Orlandi, Giulia Di Martino, Simona Fazio, Vito Michele Alessandrini, Gabriele Telera, Stefano Carosi, Mariantonia Ciliberto, Gennaro Botti, Claudio Strano, Sabrina Piccolo, Stefano Blandino, Giovanni Mol Cancer Correspondence BioMed Central 2022-07-22 /pmc/articles/PMC9306102/ /pubmed/35869553 http://dx.doi.org/10.1186/s12943-022-01617-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correspondence Donzelli, Sara Cioce, Mario Sacconi, Andrea Zanconato, Francesca Daralioti, Theodora Goeman, Frauke Orlandi, Giulia Di Martino, Simona Fazio, Vito Michele Alessandrini, Gabriele Telera, Stefano Carosi, Mariantonia Ciliberto, Gennaro Botti, Claudio Strano, Sabrina Piccolo, Stefano Blandino, Giovanni A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions |
| title | A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions |
| title_full | A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions |
| title_fullStr | A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions |
| title_full_unstemmed | A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions |
| title_short | A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions |
| title_sort | pik3ca-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306102/ https://www.ncbi.nlm.nih.gov/pubmed/35869553 http://dx.doi.org/10.1186/s12943-022-01617-6 |
| work_keys_str_mv | AT donzellisara apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT ciocemario apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT sacconiandrea apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT zanconatofrancesca apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT daraliotitheodora apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT goemanfrauke apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT orlandigiulia apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT dimartinosimona apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT faziovitomichele apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT alessandrinigabriele apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT telerastefano apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT carosimariantonia apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT cilibertogennaro apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT botticlaudio apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT stranosabrina apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT piccolostefano apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT blandinogiovanni apik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT donzellisara pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT ciocemario pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT sacconiandrea pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT zanconatofrancesca pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT daraliotitheodora pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT goemanfrauke pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT orlandigiulia pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT dimartinosimona pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT faziovitomichele pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT alessandrinigabriele pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT telerastefano pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT carosimariantonia pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT cilibertogennaro pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT botticlaudio pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT stranosabrina pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT piccolostefano pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions AT blandinogiovanni pik3camutantbreastcancermetastaticpatientderivedorganoidapproachtoevaluatealpelisibtreatmentformultiplesecondarylesions |